Amicus Therapeutics to Announce Second Quarter 2024 Financial Results on August 8, 2024
Amicus Therapeutics (Nasdaq: FOLD) has announced its upcoming second quarter 2024 financial results conference call and webcast, scheduled for August 8, 2024, at 8:30 a.m. ET. The event will cover financial results for the quarter ended June 30, 2024. Participants can access the call via phone by registering online to receive a dial-in number and personal PIN. A live audio webcast and presentation materials will be available through the Investors section of the Amicus Therapeutics website.
Amicus Therapeutics is a global biotechnology company focused on discovering, developing, and delivering novel medicines for rare diseases. The company emphasizes patient dedication and is committed to advancing a pipeline of first- or best-in-class treatments for rare diseases.
Amicus Therapeutics (Nasdaq: FOLD) ha annunciato la sua prossima conferenza telefonica e webcast sui risultati finanziari del secondo trimestre 2024, programmata per 8 agosto 2024, alle 8:30 a.m. ET. L'evento tratterà i risultati finanziari per il trimestre chiuso il 30 giugno 2024. I partecipanti possono accedere alla chiamata tramite telefono registrandosi online per ricevere un numero di accesso e un PIN personale. Una webcast audio in diretta e i materiali di presentazione saranno disponibili nella sezione Investors del sito web di Amicus Therapeutics.
Amicus Therapeutics è una azienda biotecnologica globale che si concentra sulla scoperta, sviluppo e fornitura di nuovi farmaci per malattie rare. L'azienda pone un forte accento sulla dedizione verso i pazienti ed è impegnata a far progredire un portafoglio di trattamenti di prima o migliore classe per malattie rare.
Amicus Therapeutics (Nasdaq: FOLD) ha anunciado su próxima conferencia telefónica y webcast sobre los resultados financieros del segundo trimestre de 2024, programada para el 8 de agosto de 2024, a las 8:30 a.m. ET. El evento cubrirá los resultados financieros del trimestre terminado el 30 de junio de 2024. Los participantes pueden acceder a la llamada por teléfono registrándose en línea para recibir un número de acceso y un PIN personal. Una transmisión de audio en vivo y los materiales de presentación estarán disponibles a través de la sección de Inversores del sitio web de Amicus Therapeutics.
Amicus Therapeutics es una empresa biotecnológica global que se enfoca en descubrir, desarrollar y entregar nuevos medicamentos para enfermedades raras. La compañía enfatiza la dedicación al paciente y está comprometida a avanzar en un portafolio de tratamientos de primera o mejor clase para enfermedades raras.
Amicus Therapeutics (Nasdaq: FOLD)는 2024년 2분기 재무 결과에 대한 컨퍼런스 콜 및 웹캐스트를 2024년 8월 8일 오전 8시 30분 ET에 예정하고 있다고 발표했습니다. 이 이벤트는 2024년 6월 30일에 종료된 분기의 재무 결과를 다룰 것입니다. 참가자는 온라인으로 등록하여 전화 접속 번호 및 개인 PIN을 받아 전화로 콜에 접속할 수 있습니다. 라이브 오디오 웹캐스트와 발표 자료는 Amicus Therapeutics 웹사이트의 투자자 섹션을 통해 제공됩니다.
Amicus Therapeutics는 희귀 질환을 위한 새로운 의약품을 발견, 개발 및 제공하는 데 중점을 둔 글로벌 생명공학 회사입니다. 이 회사는 환자에 대한 헌신을 강조하며, 희귀 질환을 위한 1등 또는 최고 클래스의 치료제 개발을 위해 헌신하고 있습니다.
Amicus Therapeutics (Nasdaq: FOLD) a annoncé sa prochaine conférence téléphonique et webcast sur les résultats financiers du deuxième trimestre 2024, prévue pour le 8 août 2024, à 8h30 ET. L'événement couvrira les résultats financiers pour le trimestre se terminant le 30 juin 2024. Les participants peuvent accéder à l'appel par téléphone en s'inscrivant en ligne pour recevoir un numéro de connexion et un code PIN personnel. Un webcast audio en direct et des supports de présentation seront disponibles dans la section Investisseurs du site Web d'Amicus Therapeutics.
Amicus Therapeutics est une entreprise biotechnologique mondiale axée sur la découverte, le développement et la fourniture de nouveaux médicaments pour les maladies rares. L'entreprise met l'accent sur l'engagement envers les patients et s'engage à faire avancer un portefeuille de traitements de première ou meilleure classe pour les maladies rares.
Amicus Therapeutics (Nasdaq: FOLD) hat seine nächste Telefonkonferenz und Webcast über die finanziellen Ergebnisse des zweiten Quartals 2024 angekündigt, die für 8. August 2024, 8:30 Uhr ET geplant ist. Die Veranstaltung wird die finanziellen Ergebnisse für das am 30. Juni 2024 endende Quartal behandeln. Teilnehmer können über das Online-Registrierungsformular auf die Telefonkonferenz zugreifen, um eine Einwahlnummer und eine persönliche PIN zu erhalten. Ein Live-Audio-Webcast und Präsentationsmaterialien werden im Investorenbereich der Webseite von Amicus Therapeutics verfügbar sein.
Amicus Therapeutics ist ein globales Biotechnologieunternehmen, das sich auf die Entdeckung, Entwicklung und Bereitstellung neuartiger Medikamente für seltene Krankheiten konzentriert. Das Unternehmen legt großen Wert auf die Patientenorientierung und setzt sich dafür ein, ein Portfolio von erstklassigen oder besten Behandlungsoptionen für seltene Krankheiten voranzutreiben.
- Timely financial reporting with scheduled Q2 2024 results announcement
- Continued focus on rare disease treatments, potentially addressing unmet medical needs
- Multiple access options for investors (phone and webcast) for the earnings call
- None.
PRINCETON, N.J., July 30, 2024 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that the Company will host a conference call and live audio webcast on Thursday, August 8, 2024, at 8:30 a.m. ET to discuss financial results for the second quarter ended June 30, 2024.
Participants and investors interested in accessing the call by phone will need to register using the online registration form. After registering, all phone participants will receive a dial-in number along with a personal PIN to access the event. A live audio webcast and related presentation materials can also be accessed via the Investors section of the Amicus Therapeutics corporate website at ir.amicusrx.com. Web participants are encouraged to register on the website 15 minutes prior to the start of the call.
An archived webcast and accompanying slides will be available on the Company's website shortly after the conclusion of the live event.
About Amicus Therapeutics
Amicus Therapeutics (Nasdaq: FOLD) is a global, patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare diseases. With extraordinary patient focus, Amicus Therapeutics is committed to advancing and expanding a pipeline of cutting-edge, first- or best-in-class medicines for rare diseases. For more information please visit the company’s website at www.amicusrx.com, and follow on X and LinkedIn.
FOLD–G
FAQ
When will Amicus Therapeutics (FOLD) release its Q2 2024 financial results?
How can investors access Amicus Therapeutics' (FOLD) Q2 2024 earnings call?
What is the main focus of Amicus Therapeutics (FOLD)?
What period will Amicus Therapeutics' (FOLD) Q2 2024 financial results cover?
